IN8bio, Inc. (INAB)
NASDAQ: INAB · Real-Time Price · USD
0.1705
-0.0256 (-13.05%)
Mar 31, 2025, 2:27 PM EDT - Market open
IN8bio Stock Forecast
INAB's stock price has decreased by -83.79% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
The 2 analysts with 12-month price forecasts for IN8bio stock have an average target of 3.60, with a low estimate of 1.20 and a high estimate of 6.00. The average target predicts an increase of 2,011.44% from the current stock price of 0.17.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for IN8bio stock from 2 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Oct '24 | Nov '24 | Dec '24 | Jan '25 | Feb '25 | Mar '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 3 | 2 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 1 | 1 | 1 | 1 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 3 | 3 | 3 | 3 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $8 → $6 | Strong Buy | Maintains | $8 → $6 | +3,419.06% | Mar 14, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $8 | Strong Buy | Reiterates | $8 | +4,592.08% | Feb 12, 2025 |
| Jones Trading | Jones Trading | Hold → Strong Buy Upgrades $1.2 | Hold → Strong Buy | Upgrades | $1.2 | +603.81% | Feb 11, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $8 | Strong Buy | Reiterates | $8 | +4,592.08% | Nov 26, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $13 → $8 | Strong Buy | Maintains | $13 → $8 | +4,592.08% | Nov 13, 2024 |
Financial Forecast
Revenue This Year
n/a
from 88.41M
Revenue Next Year
n/a
EPS This Year
-0.21
from -0.57
EPS Next Year
-0.23
from -0.21
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | n/a | n/a | 20.1M | ||
| Avg | n/a | n/a | 6.9M | ||
| Low | n/a | n/a | n/a |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -0.18 | -0.19 | -0.15 | ||
| Avg | -0.21 | -0.23 | -0.27 | ||
| Low | -0.25 | -0.27 | -0.43 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.